Skip to content
naulon

Not checkedNot checked for notices yet.

Hallux valgus and percutaneous surgery: treatment evaluation

Antero Tavares Cordeiro Neto, Valter Pereira Neto, Jorge Eduardo de Schoucair Jambeiro and 4 more

Journal of the Foot & Ankle · 2022

doi:10.30795/jfootankle.2022.v16.1648 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objective: Evaluate the treatment of hallux valgus through percutaneous surgery. Methods: This is a systematic review, and the search was conducted on PubMed/Medline and Virtual Health Library (VHL) databases. The search included studies that addressed percutaneous surgery and analyzed the American Orthopaedic Foot & Ankle Society (AOFAS) score, published between 2013 and 2018, as original studies, in English, Portuguese and Spanish. Results: One-hundred and eighty-five articles were identified in the databases, 19 were selected for STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) application, and five were included in the systematic review. The majority of the studies were European; the age of the patient was from 17 to 78 years, who suffered from mild to severe deformities, which were evaluated radiographically and through the AOFAS scale, then submitted to minimally invasive surgeries. Postoperative follow-up was from six months to ten years. Conclusion: The percutaneous technique for hallux valgus correction has shown good results, little surgical trauma, few complications, rapid recovery, return to activities and high satisfaction with the result. Level of Evidence I; Systematic Review of Level I Studies.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.